CHS-828 (GMX1778) is a potent small molecule NAMPT inhibitor with an IC50 below 25 nM, disrupting cellular NAD+ biosynthesis. It is a valuable research tool for studying cancer metabolism and has demonstrated antitumor efficacy in both cellular assays and in vivo xenograft models.